Biocorp Production

Biocorp Production Receivables

Delisted

The Accounts Receivable of Biocorp Production (ALCOR.PA) as of Nov 5, 2026 is 20,600.00 EUR. In the previous year, Accounts Receivable was 138,000.00 EUR — a change of -85.07% (lower).

Receivables

20,600.00EUR

YoY

-85.07%

Last updated:

Accounts Receivable of Biocorp Production is 2022 20,600.00 EUR. Accounts Receivable of Biocorp Production was 2021 138,000.00 EUR. It decreases by -85.07% lower compared to the previous year.

The Biocorp Production Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2015
459,800.00 EUR
Jan 1, 2016
10,600.00 EUR
Jan 1, 2017
207,600.00 EUR
Jan 1, 2018
122,900.00 EUR
Jan 1, 2019
195,500.00 EUR
Jan 1, 2020
36,400.00 EUR
Jan 1, 2021
138,000.00 EUR
Jan 1, 2022
20,600.00 EUR
The Biocorp Production Receivables history
YEARReceivablesYoY
20,600.00EUR-85.07%
138,000.00EUR+279.12%
36,400.00EUR-81.38%
195,500.00EUR+59.07%
122,900.00EUR-40.80%
207,600.00EUR+1,858.49%
10,600.00EUR-97.69%
459,800.00EUR+83.92%
250,000.00EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biocorp Production Stock analysis

What does Biocorp Production do? Biocorp Production SA is a French company in the medical technology industry that manufactures innovative solutions for drug administration and injections. It was founded in 2004 under the name Biocorp sur mesure by Eric Dessertenne and later transformed into Biocorp Production SA. The business model of Biocorp Production SA is to produce innovative medical devices that can be used in medical applications. The company specializes in the development of smart devices that support injection administration. The devices produced by Biocorp can be operated by medical professionals or by patients themselves. One of the core areas of Biocorp Production SA is the development of smart medical technologies that aid in medication management. One such product is Vyoo, a device that assists patients in injecting medications. It is a digital device that facilitates injection administration and makes dosing safer. In addition to developing smart devices, Biocorp also offers other services, such as in the field of clinical trials for medical applications. The company works closely with pharmaceutical companies to develop medical devices and solutions for drug administration. Another important product is Mallya, an intelligent insulin administration system specifically designed for diabetes patients. It enables automated insulin administration tailored to the patient's needs, thereby improving their quality of life. Furthermore, Biocorp Production SA is also involved in the field of wearable medical technology. One example of a wearable device is Easylog, an electronic device for monitoring medical conditions. This device is particularly useful for patients with chronic diseases such as diabetes or asthma. Over the years, Biocorp Production SA has received numerous awards for its innovative products and services. For example, the company received the Innovation Award at the "Innovation Awards" in Paris in 2017 for the Mallya device. Overall, the company currently employs over 60 employees and has its headquarters in Issoire. It has branches in Germany and the USA. The products of Biocorp Production SA are sold in more than 80 countries worldwide. In summary, Biocorp Production SA is a leading provider of smart medical devices for drug administration and injections. The company strives to develop innovative solutions for the medical industry that are tailored to the needs of patients and medical professionals. With the products of Biocorp Production SA, medication administration becomes safer, easier, and more accurate. Biocorp Production is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biocorp Production stock

Accounts Receivable of Biocorp Production is 20,600.00 EUR in 2022.

Accounts Receivable of Biocorp Production changed from 138,000.00 EUR to 20,600.00 EUR, representing a -85.07% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Biocorp Production since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Biocorp Production historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Biocorp Production

All Key Metrics — Biocorp Production